US 7820181
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 7820181 (Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K39/00, A61K39/12